Pimavanserin continuation lower psychosis relapse risk in patient with dementia-related psychosis
1. Pimavanserin was shown to lead to a lower risk of relapse of psychosis in patients who had an initial ...
1. Pimavanserin was shown to lead to a lower risk of relapse of psychosis in patients who had an initial ...
1. Methylphenidate provides a treatment approach with modest but potentially clinically significant benefit for apathy symptoms in patients with Alzheimer ...
1. flortaucipir positron emission tomography (“Tau PET”) imaging predicted changes in mental status with a stronger effect size than standard ...
1. Older patients presenting to the dentist with missing teeth were more likely to have Alzheimer’s Disease. Evidence Rating Level: ...
1. Systematic review found that social prescribing was associated with a reduction in depressive symptoms in patients with dementia without ...
1. Donanemab resulted in a modestly better composite score for cognition and the ability to perform activities of daily living ...
1. There is a significantly increased risk of dementia in patients with previously diagnosed depression, with the highest risk observed ...
1. While well-tolerated in early and mild Alzheimer’s disease, the BACE1 inhibitor lanabecestat was generally ineffective in slowing cognitive and ...
Androgen deprivation therapy (ADT) is used in the treatment of prostate cancer, either alone or in combination with other treatment ...
1. In this prospective cohort, Alzheimer’s Disease biomarkers derived from imaging, namely amyloid, tau, and cortical thickness estimates, had a ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.